Skip to main content
Premium Trial:

Request an Annual Quote

And the Hits Just Keep on Coming

In two articles from the Wall Street Journal today, more bad news for pharma and biotech. Novartis announced that it plans to lay off some 2,500 people globally -- that represents about 2.5 percent of the company's work force, according to the article. In another story, the Journal reports that Biogen has given up its search for a buyer after several weeks of searching "turned up no serious offers." The company's stock plummeted 27 percent on the news.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.